Integration of meningococcal conjugate vaccination

Integration of meningococcal conjugate vaccination

  • CN 101,163,508 A
  • Filed: 01/13/2006
  • Published: 04/16/2008
  • Est. Priority Date: 01/14/2005
  • Status: Active Application
First Claim
Patent Images

1. the method for the disease that causes with the opposing Neisseria meningitidis of an immune human patients, this method comprise give described human patients a kind of contain (a) and (b), (c) and (d) in the step of compositions of at least two kinds of materials:

  • (a) capsular saccharides of (i) serogroups A Neisseria meningitidis and the (ii) conjugate of tetanus toxoid;

    (b) (i) capsular saccharides of serogroup C Neisseria meningitidis and the (ii) conjugate of tetanus toxoid;

    (c) (i) capsular saccharides of sero-group W135 Neisseria meningitidis and the (ii) conjugate of tetanus toxoid;

    And (d) capsular saccharides and the (ii) conjugate of tetanus toxoid of (i) sero-group Y Neisseria meningitidis, wherein, described patient has used following (a) and/or (b) preimmunization mistake;

    (a) tetanus toxoid;

    (b) (i) capsular saccharides of the biology except that Neisseria meningitidis and the (ii) conjugate of tetanus toxoid.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×